Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Evaluating the MyoTrain System for Individuals with Trans-radial Limb Loss

Official title: Regulatory Clearance of a Rehabilitation System for Individuals With Upper Limb Loss

Run by Infinite Biomedical Technologies · NCT05888428 · Data updated 2026-11-12

This study is testing if the MyoTrain system can help people who have lost their arm below the elbow learn to use prosthetics better compared to regular training methods.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment16 (estimated)
SponsorInfinite Biomedical Technologies
Industry-sponsored
Locations1 site (Grand Rapids, Michigan)
StatusRecruiting
StartedFebruary 2, 2024
Main results expectedAugust 31, 2026
Study endsAugust 31, 2026
Registry record updatedOctober 29, 2025
Trial IDNCT05888428 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 18 and older with unilateral trans-radial limb loss who are suitable for a myoelectric prosthesis.

Probably not a fit

Patients with prior experience using pattern recognition control or those with unhealed wounds or significant cognitive, neurological, or physical deficits may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to assess the efficacy of the MyoTrain system in individuals who have experienced trans-radial upper-limb loss. Sixteen participants will be randomly assigned to either a control group using standard motor imagery training or a group utilizing the MyoTrain system over a 206-day period. The study will evaluate the transfer of skills to prosthetic control, the correlation of virtual outcome measures with real-world functional outcomes, and improvements in clinical outcomes through various metrics. Participants will undergo a pre-prosthetic training period before receiving their prosthetic devices and occupational therapy.

Why it matters

Potential benefit: If successful, this study could enhance the functional capabilities of individuals with trans-radial limb loss through improved prosthetic control.

How similar studies have gone: While the MyoTrain system is a novel approach, similar studies have shown promise in improving prosthetic control through advanced training techniques.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Trans-radial unilateral limb loss
* Candidate for a 2+ degree-of-freedom myoelectric pattern recognition prosthesis as determined by prosthetist
* Fluent in English
* Age of 18 years or greater

Exclusion Criteria:

* Prior experience with pattern recognition control
* Patients with a residual limb that is unhealed from the amputation surgery
* Patients with easily damaged or sensitive skin who would not tolerate EMG electrodes
* Unhealed wounds
* Significant cognitive deficits as determined upon clinical evaluation
* Significant neurological deficits as determined upon clinical evaluation
* Significant physical deficits of the residual limb impacting full participation in the study as determined upon clinical evaluation
* Uncontrolled pain or phantom pain impactive full participation in the study as determined upon clinical evaluation
* Serious uncontrolled medical problems as judged by the project therapist

Where it's running

  • Hanger Clinic - Grand Rapids
    Grand Rapids, Michigan, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.